Cargando…

Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case

BACKGROUND: Immunoglobulin G4–related ophthalmic disease (IgG4-ROD) accounts for 22% of Japanese lymphoproliferative orbital disease and occurs in 4%–34% of patients with IgG4-related disease, according to the largest case series published to date. Because the optic nerve mass often appears as a tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Noda, Ryuichi, Inoue, Tomohiro, Tsunoda, Sho, Akabane, Atsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Neurological Surgeons 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241348/
https://www.ncbi.nlm.nih.gov/pubmed/35855308
http://dx.doi.org/10.3171/CASE20170
_version_ 1784737786506510336
author Noda, Ryuichi
Inoue, Tomohiro
Tsunoda, Sho
Akabane, Atsuya
author_facet Noda, Ryuichi
Inoue, Tomohiro
Tsunoda, Sho
Akabane, Atsuya
author_sort Noda, Ryuichi
collection PubMed
description BACKGROUND: Immunoglobulin G4–related ophthalmic disease (IgG4-ROD) accounts for 22% of Japanese lymphoproliferative orbital disease and occurs in 4%–34% of patients with IgG4-related disease, according to the largest case series published to date. Because the optic nerve mass often appears as a tumor-like lesion, it is important, although difficult, to differentiate IgG4-ROD from other orbital tumors and diseases, and biopsy is essential for diagnosis. Here, the authors describe the surgical management of an IgG4-ROD case. OBSERVATIONS: A 63-year-old man presented to the authors’ hospital with proptosis and visual impairment. Ophthalmic examination revealed intraocular hypertension. IgG4-related disease with an ophthalmic lesion was suspected on the basis of a blood test and imaging studies. Transcranial biopsy with extraorbital decompression was performed. The patient’s symptoms, including visual impairment, improved 3 days after operation, and his IgG4-related disease resolved after corticosteroid treatment. LESSONS: The standard treatment for IgG4-related disease is systemic corticosteroid therapy. However, this treatment should not be administered to patients with IgG4-ROD who a high risk of blindness. In this case, the authors completed a diagnostic and symptom-relieving transcranial biopsy without affecting the patient’s aesthetic characteristics. This is the first study, to our knowledge, to report extraorbital decompression via a transcranial approach as a surgical option for IgG4-ROD.
format Online
Article
Text
id pubmed-9241348
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association of Neurological Surgeons
record_format MEDLINE/PubMed
spelling pubmed-92413482022-07-18 Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case Noda, Ryuichi Inoue, Tomohiro Tsunoda, Sho Akabane, Atsuya J Neurosurg Case Lessons Case Illustration BACKGROUND: Immunoglobulin G4–related ophthalmic disease (IgG4-ROD) accounts for 22% of Japanese lymphoproliferative orbital disease and occurs in 4%–34% of patients with IgG4-related disease, according to the largest case series published to date. Because the optic nerve mass often appears as a tumor-like lesion, it is important, although difficult, to differentiate IgG4-ROD from other orbital tumors and diseases, and biopsy is essential for diagnosis. Here, the authors describe the surgical management of an IgG4-ROD case. OBSERVATIONS: A 63-year-old man presented to the authors’ hospital with proptosis and visual impairment. Ophthalmic examination revealed intraocular hypertension. IgG4-related disease with an ophthalmic lesion was suspected on the basis of a blood test and imaging studies. Transcranial biopsy with extraorbital decompression was performed. The patient’s symptoms, including visual impairment, improved 3 days after operation, and his IgG4-related disease resolved after corticosteroid treatment. LESSONS: The standard treatment for IgG4-related disease is systemic corticosteroid therapy. However, this treatment should not be administered to patients with IgG4-ROD who a high risk of blindness. In this case, the authors completed a diagnostic and symptom-relieving transcranial biopsy without affecting the patient’s aesthetic characteristics. This is the first study, to our knowledge, to report extraorbital decompression via a transcranial approach as a surgical option for IgG4-ROD. American Association of Neurological Surgeons 2021-02-22 /pmc/articles/PMC9241348/ /pubmed/35855308 http://dx.doi.org/10.3171/CASE20170 Text en © 2021 The authors https://creativecommons.org/licenses/by-nc-nd/4.0/CC BY-NC-ND 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Case Illustration
Noda, Ryuichi
Inoue, Tomohiro
Tsunoda, Sho
Akabane, Atsuya
Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case
title Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case
title_full Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case
title_fullStr Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case
title_full_unstemmed Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case
title_short Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case
title_sort surgical management for igg4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case
topic Case Illustration
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241348/
https://www.ncbi.nlm.nih.gov/pubmed/35855308
http://dx.doi.org/10.3171/CASE20170
work_keys_str_mv AT nodaryuichi surgicalmanagementforigg4relatedophthalmicdiseasebyatranscranialbiopsycombinedwithextraorbitaldecompressionillustrativecase
AT inouetomohiro surgicalmanagementforigg4relatedophthalmicdiseasebyatranscranialbiopsycombinedwithextraorbitaldecompressionillustrativecase
AT tsunodasho surgicalmanagementforigg4relatedophthalmicdiseasebyatranscranialbiopsycombinedwithextraorbitaldecompressionillustrativecase
AT akabaneatsuya surgicalmanagementforigg4relatedophthalmicdiseasebyatranscranialbiopsycombinedwithextraorbitaldecompressionillustrativecase